Monarch Medical Research   Report issue

Academic/Hospital Phase 4
Founded: Charlotte NC United States (2003)

Organization Overview

First Clinical Trial
2004
NCT00131443
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

atomoxetine (strattera) (1 trial)

topiramate (topamax) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Disease (Phase 4)

Hyperkinesis (Phase 4)

Migraine Disorders (Phase 3)

Migraine with Aura (Phase 3)

Vomiting (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 2